Thursday, September 10, 2015

Actelion made $2.5 billion bid for ZS Pharma last month: Bloomberg

(Reuters) - Swiss-based drugmaker Actelion Ltd had offered to buy U.S. biotech company ZS Pharma Inc last month in a deal valued at $2.5 billion, Bloomberg reported, citing people with knowledge of the matter said.


Latest health news from http://reuters.us.feedsportal.com/c/35217/f/654207/s/49bed0f3/sc/7/l/0L0Sreuters0N0Carticle0C20A150C0A90C10A0Cus0Ezs0Epharma0Em0Ea0Eactelion0EidUSKCN0ARA2HU20A150A910A0DfeedType0FRSS0GfeedName0FhealthNews/story01.htm

No comments:

Post a Comment